The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...
Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the ...
Icad (NASDAQ: ICAD) Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium ...
Medpage Today on MSN6h
HER2 Low and Ultralow Designations Open Door to Expansion of ADCs in Breast CancerA HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...
Data from a late-stage study shows that LLY's experimental oral drug benefited certain breast cancer patients when used as ...
Project EVOLVE, funded by Daiichi Sankyo and AstraZeneca, to be presented at the 2024 San Antonio Breast Cancer Symposium -- NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Novellia, Inc., an AI-enabled ...
A new AI-powered blood test is the first to detect signs of breast cancer in its earliest stages when it is “far more easily ...
PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with ...
Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of ...
From December 1st to 5th, 2024, RSNA 2024-the largest and most future-oriented top medical event in the global radiology ...
Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback